Mumbai: Global pharma major, Lupin Limited, has received approval from the United States Food and Drug Administration (U.S.

Mumbai: Lupin Diagnostics Limited, a wholly owned subsidiary of global pharma major Lupin Limited, has received 100 percent ...

Global pharma major Lupin Ltd today announced that it has received the Establishment Inspection Report from the United States ...

As the preeminent source of professional medical education for the ... India, with products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and ...

The ruling blocks Lupin and Zydus Life from selling their generic version of Mirabegron, the bioequivalent of Astellas' ...

“We are a prescription product," Srinivasan told ... at the intersection of pharmaceuticals and medical technology," the report states. Also Read: Lupin recalls over 16,000 bottles of generic ...

Global pharma major Lupin Limited (Lupin) on Thursday announced that it has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (US FDA), for ...

SLOUGH, England, April 02, 2025--(BUSINESS WIRE)--Lupin Healthcare (UK) Limited, the wholly owned subsidiary of global pharma major Lupin Limited (Lupin) announced today the acquisition of Renascience ...

Lupin announced that it has received the Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (USFDA) for drug-medical device combination products at its injectable ...

Lupin Healthcare, a wholly owned subsidiary of Slough-based Lupin, has acquired a pharmaceutical company which is the sole supplier of four specialty products addressing unmet medical needs in the UK.

Lupin’s injectable facility in Nagpur receives EIR from US FDA: Our Bureau, Mumbai Saturday, April 19, 2025, 13:40 Hrs [IST] Global pharma major Lupin Limited (Lupin) announced ...